Back to search

Virginia Commonwealth University

MITOCHONDRIAL THERAPEUTICS DURING ISCHEMIA-REPERFUSION; MODULATION OF COMPLEX I: EFFECT OF METFORMIN.

Abstract

dc:description.abstract

The modulation of the electron transport during ischemia-reperfusion has been shown to be protective. We hypothesized that metformin, a Complex I inhibitor, may exhibit characteristics of a pharmacological agent that could achieve long-term therapeutic intervention against ischemia-reperfusion injury. Mitochondria were harvested from adult male mice and incubated with or without metformin at 30oC for 15 minutes, while being shaken at 300 rpm. Metformin decreased Complex I oxidative phosphorylation and Complex I activity. However, metformin also increased injury and decreased the maximum membrane potential. Even though there was a decrease in maximum membrane potential, the proton motive force (PMF) was still intact as the ADP/O ratio was not affected. In conclusion, metformin does exhibit some characteristics of a drug that could achieve long-term therapeutic benefit against ischemia-reperfusion.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Physiology and Biophysics

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sunu, Shawn Y
Contributors dc:contributor
  • Dr. Edward J. Lesnefsky Jr., M.D.
  • Dr. Clive M Baumgarten, PhD
  • Dr. Anindita Das, PhD

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Sunu, Shawn Y. MITOCHONDRIAL THERAPEUTICS DURING ISCHEMIA-REPERFUSION; MODULATION OF COMPLEX I: EFFECT OF METFORMIN.. Thesis thesis, https://doi.org/10.25772/GWT4-0F13